| Views | |
|---|---|
| Evaluating the impact of bevacizumab as a targeted therapy in combination with standard chemotherapy on disease progression and treatment outcomes in ovarian cancer | 5 |
| April 2026 | May 2026 | June 2026 | July 2026 | August 2026 | September 2026 | October 2026 | |
|---|---|---|---|---|---|---|---|
| Evaluating the impact of bevacizumab as a targeted therapy in combination with standard chemotherapy on disease progression and treatment outcomes in ovarian cancer | 0 | 0 | 0 | 0 | 0 | 2 | 3 |
| Views | |
|---|---|
| 104-106.pdf | 2 |
| Views | |
|---|---|
| Belarus | 2 |
| Singapore | 1 |
| Views | |
|---|---|
| Minsk | 2 |
| Singapore | 1 |